To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
2 Current news of Actelionrss
Actelion Ltd and Roche have announced today that they have entered into an exclusive worldwide collaboration to jointly develop and commercialize Actelion's selective S1P1 receptor agonist, an immunomodulator with the potential for once-a-day oral dosing. The compound is currently being developed ...
Actelion/Merck Renin alliance achieves third milestone
Actelion Ltd. announced that the renin alliance with Merck & Co., Inc., has achieved its third milestone. The alliance has entered into man its first compound, a new renin inhibitor. This start of full clinical development triggers a milestone payment by Merck to Actelion of USD 7 ...